Search results (70)
« Back to NewsExogene Raises $2M (£1.5M) for Its AI Platform to Discover Cell Therapies for Cancer
27 April 2022
Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, has raised $2M in funding to develop its artificial intelligence (AI) platform for T-cell receptor discovery.
Oxford Silk Phage Technologies awarded three consecutive grants from OxLEP’s ISfB programme
30 March 2022
OSPT has been awarded £680K to advance its disruptive antibacterial technology.
Introducing Alethiomics
1 February 2022
Alethiomics Ltd is a pre-clinical biotech company harnessing the power of single cell multiomic technology to discover and develop life-changing treatments for patients with blood cancer.
Exogene selected for KQ Labs accelerator programme
4 November 2021
Exogene has been selected as one of ten innovative startup companies, working at the interface of biomedical and data science, to receive personalised mentoring and coaching as part of the KQ Labs accelerator programme.
Introducing Oxford Silk Phage Technologies
4 July 2021
Oxford Silk Phage Technologies combines the long-term expertise of clinicians, entrepreneurs and scientists with a shared passion for developing superior, natural antibacterial biomaterials to help people live more active and longer lives.
Evolvere Biosciences joins the BioEscalator community after winning the OUBT Biohackathon 2021
4 July 2021
Evolvere joins our community for three months after winning the OUBT Biohacakthon 2021 BioEscalator sponsored prize.
Introducing Exogene
1 June 2021
Exogene is a biotechnology company discovering novel T-cell receptor (TCR)-based cell therapies to treat advanced solid tumours.
HRH The Earl of Wessex visits Oxfordshire virtually
17 May 2021
HRH The Earl of Wessex speaks with Oxfordshire entrepreneurs, including Atherton Mutombwera, CEO of Hutano Diagnostics.
Oxford Seed Fund announces 2020 investments in Hutano Diagnostics
14 September 2020
The Oxford Seed Fund (OSF) is a student-led seed fund and an initiative of Said Business School’s Entrepreneurship Centre. Of the hundreds of start-up applications the team reviewed, OSF is excited to announce one of this year’s start-up investments is Hutano Diagnostics.
Agile start-ups partner with academics to find COVID-19 solutions
14 July 2020
Three companies at Oxford’s BioEscalator are developing new detection methods and have discovered potential therapeutics in the fight against COVID-19.